CGON vs. UTG

Last updated Aug 1, 2026

CGON (CG Oncology, Inc) and UTG (Reaves Utility Income Trust) are both stocks. CGON operates in Biotechnology (Healthcare), while UTG operates in Asset Management (Financial Services). Over the past year, CGON returned 170.58% vs 7.03% for UTG. Their 0.14 correlation means their historical movements had little consistent relationship.

Performance

CGON vs. UTG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CG Oncology, Inc (CGON) and Reaves Utility Income Trust (UTG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CGON achieves a 71.46% return, which is significantly higher than UTG's 8.27% return.

CGON

• 1D: -2.52%
• 1M: 1.18%
• 6M: 36.77%
• YTD: 71.46%
• 1Y: 170.58%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: 42.95%

UTG

• 1D: 0.65%
• 1M: -2.98%
• 6M: 4.86%
• YTD: 8.27%
• 1Y: 7.03%
• 3Y*: 19.80%
• 5Y*: 9.49%
• 10Y*: 9.43%
• ALL TIME*: 10.76%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
CGON CG Oncology, Inc	$59.82M	$66.58M	$70.32M
UTG Reaves Utility Income Trust	$12.10M	$10.96M	$10.49M

CGON vs. UTG - Yearly Performance Comparison

	2026 (YTD)	2025	2024
CGON CG Oncology, Inc	71.46%	44.77%	-1.10%
UTG Reaves Utility Income Trust	8.27%	23.24%	31.54%

Correlation

The correlation between CGON and UTG is 0.14, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.14
Correlation (All Time) Calculated using the full available price history since Jan 25, 2024	0.14

Fundamentals

Market Cap CGON : $6.28B UTG : $3.52B
EPS CGON : -$1.59 UTG : $22.08
PS Ratio CGON : 1.12K UTG : 6.58
PB Ratio CGON : 5.51 UTG : 0.87
Total Revenue (TTM) CGON : $5.07M UTG : $532.00M
Gross Profit (TTM) CGON : -$2.54M UTG : $478.68M
EBITDA (TTM) CGON : -$191.51M UTG : $2.08B

Return for Risk

CGON vs. UTG — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CGON

CGON Risk / Return Rank: 96
CGON Sharpe Ratio Rank: 97
CGON Sortino Ratio Rank: 96
CGON Omega Ratio Rank: 93
CGON Calmar Ratio Rank: 97
CGON Martin Ratio Rank: 97

UTG

UTG Risk / Return Rank: 55
UTG Sharpe Ratio Rank: 59
UTG Sortino Ratio Rank: 49
UTG Omega Ratio Rank: 49
UTG Calmar Ratio Rank: 58
UTG Martin Ratio Rank: 58

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CGON vs. UTG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CG Oncology, Inc (CGON) and Reaves Utility Income Trust (UTG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CGON	UTG	Difference
Sharpe ratio: Return per unit of total volatility	2.88	0.38	+2.50
Sortino ratio: Return per unit of downside risk	3.71	0.61	+3.10
Omega ratio: Gain probability vs. loss probability	1.41	1.08	+0.34
Calmar ratio: Return relative to maximum drawdown	6.12	0.54	+5.58
Martin ratio: Return relative to average drawdown	19.55	1.16	+18.39

CGON vs. UTG - Sharpe Ratio Comparison

The current CGON Sharpe Ratio is 2.88, which is higher than the UTG Sharpe Ratio of 0.38. The chart below compares the historical Sharpe Ratios of CGON and UTG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CGON vs. UTG - Drawdown Comparison

The maximum CGON drawdown since its inception was -67.47%, roughly equal to the maximum UTG drawdown of -67.77%. Use the drawdown chart below to compare losses from any high point for CGON and UTG.

Drawdown Indicators

	CGON	UTG	Difference
Max Drawdown Largest peak-to-trough decline	-67.47%	-67.77%	+0.30%
Max Drawdown (1Y) Largest decline over 1 year	-27.41%	-12.51%	-14.90%
Max Drawdown (3Y) Largest decline over 3 years	—	-14.95%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-26.54%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-47.91%	—
Current Drawdown Current decline from peak	-5.38%	-10.60%	+5.22%
Average Drawdown Average peak-to-trough decline	-24.86%	-8.72%	-16.14%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.57%	5.87%	+2.70%

Volatility

CGON vs. UTG - Volatility Comparison

CG Oncology, Inc (CGON) has a higher volatility of 15.19% compared to Reaves Utility Income Trust (UTG) at 5.22%. This indicates that CGON's price experiences larger fluctuations and is considered to be riskier than UTG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CGON	UTG	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.19%	5.22%	+9.97%
Volatility (6M) Calculated over the trailing 6-month period	34.97%	14.11%	+20.86%
Volatility (1Y) Calculated over the trailing 1-year period	58.21%	18.00%	+40.21%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	65.95%	17.17%	+48.78%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	65.95%	21.70%	+44.25%

Dividends

CGON vs. UTG - Dividend Comparison

CGON has not paid dividends to shareholders, while UTG's dividend yield for the trailing twelve months is around 6.27%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CGON CG Oncology, Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
UTG Reaves Utility Income Trust	6.27%	6.42%	7.19%	8.53%	8.07%	6.35%	6.59%	5.69%	6.86%	6.21%	9.02%	6.86%

Financials

Frequently Asked Questions

Can I hold both CGON and UTG in my portfolio?

CGON and UTG have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CGON or UTG?

CGON has higher volatility (15.19%) compared to UTG (5.22%). In terms of maximum drawdown, CGON dropped -67.47% vs UTG's -67.77%.

Which has better risk-adjusted returns?

CGON currently has the higher Sharpe Ratio (2.88 vs 0.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.